Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In preclinical studies, lung intratumoral Escherichia was associated with a pro-inflammatory tumor microenvironment and decreased metastases within lung tissue. In 849 pts who underwent a therapy with Immune checkpoint inhibitors (ICIs), a median of 30 bacterial reads was detected per sample (inter-quartile range (18-85)). Among 68 pts with paired primary/metastatic samples, the bacterial spectra were similar in both sites, suggesting that tumor resident bacteria might travel with cancer cells to distant sites
Antibiotic use within 30 days of tumor sampling was associated with [decrease…